Reduced Cx43 gap junction plaque expression differentiates thyroid carcinomas from benign disease

Archives of Otolaryngology - Head and Neck Surgery

Volumn 137, Issue 11, 2011, Pages 1161-1165

  Darr, E Ashlie ^a   Patel, Anand D ^a   Yu, Guopei ^a   Komorowski, Zbigniew ^a   McCormick, Steven ^a   Tiwari, Raj ^b   Schantz, Stimson P ^a   Geliebter, Jan ^b  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43;

ADENOMA; ADULT; ARTICLE; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GOITER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PROGNOSIS; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; CONNEXIN 43; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; THYROID DISEASES; THYROID NEOPLASMS; THYROIDECTOMY; TUMOR MARKERS, BIOLOGICAL;

EID: 81855199719     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2011.186     Document Type: Article

References (20)

1. Munari-Silem Y, Guerrier A, Fromaget C, Rabilloud R, Gros D, Rousset B. Differential control of connexin-32 and connexin-43 expression in thyroid epithelial cells: evidence for a direct relationship between connexin-32 expression and histiotypic morphogenesis. Endocrinology. 1994;135(2):724-734. (Pubitemid 24241256)
2. Statuto M, Audebet C, Tonoli H, Selmi-Ruby S, Rousset B, Munari-Silem Y. Restoration of cell-to-cell communication in thyroid cell lines by transfection with and stable expression of the connexin-32 gene: impact on cell proliferation and tissue-specific gene expression. J Biol Chem. 1997;272(39):24710-24716. (Pubitemid 27418691)
3. Tonoli H, Flachon V, Audebet C, et al. Formation of three-dimensional thyroid follicle-like structures by polarized FRT cells made communication competent by transfection and stable expression of the connexin-32 gene. Endocrinology. 2000;141(4):1403-1413. (Pubitemid 32269108)
4. Leithe E, Kjenseth A, Bruun J, Sirnes S, Rivedal E. Inhibition of connexin 43 gap junction channels by the endocrine disruptor ioxynil. Toxicol Appl Pharmacol. 2010;247(1):10-17.
5. Naoi Y, Miyoshi Y, Taguchi T, et al. Connexin26 expression is associated with aggressive phenotype in human papillary and follicular thyroid cancers. Cancer Lett. 2008;262(2):248-256.
6. Guerrier A, Fonlupt P, Morand I, et al. Gap junctions and cell polarity: connexin32 and connexin43 expressed in polarized thyroid epithelial cells assemble into separate gap junctions, which are located in distinct regions of the lateral plasma membrane domain. J Cell Sci. 1995;108(pt 7):2609-2617.
7. Atkinson B, ed. Atlas of Diagnostic Cytopathology. 2nd ed. Philadelphia, PA: WB Saunders Co; 2003.
8. Leithe E, Kjenseth A, Sirnes S, Stenmark H, Brech A, Rivedal E. Ubiquitylation of the gap junction protein connexin-43 signals its trafficking from early endosomes to lysosomes in a process mediated by Hrs and Tsg101. J Cell Sci. 2009; 122(pt 21):3883-3893.
9. Mesnil M. Connexins and cancer. Biol Cell. 2002;94(7-8):493-500. (Pubitemid 36113699)
10. Yamasaki H, Naus CC. Role of connexin genes in growth control. Carcinogenesis. 1996;17(6):1199-1213. (Pubitemid 26196330)
11. Langlois S, Cowan KN, Shao Q, Cowan BJ, Laird DW. The tumor-suppressive function of connexin43 in keratinocytes is mediated in part via interaction with caveolin-1. Cancer Res. 2010;70(10):4222-4232.
12. Qin H, Shao Q, Curtis H, et al. Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication. J Biol Chem. 2002;277(32):29132-29138.
13. Eghbali B, Kessler JA, Reid LM, Roy C, Spray DC. Involvement of gap junctions in tumorigenesis: transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proc Natl Acad Sci U S A. 1991;88(23):10701-10705. (Pubitemid 21915905)
14. Goldberg GS, Bechberger JF, Tajima Y, et al. Connexin43 suppresses MFG-E8 while inducing contact growth inhibition of glioma cells. Cancer Res. 2000; 60(21):6018-6026.
15. Omori Y, Yamasaki H. Gap junction proteins connexin32 and connexin43 partially acquire growth-suppressive function in HeLa cells by deletion of their C-terminal tails. Carcinogenesis. 1999;20(10):1913-1918. (Pubitemid 29476116)
16. Avanzo JL, Mesnil M, Hernandez-Blazquez FJ, et al. Increased susceptibility to urethane-induced lung tumors in mice with decreased expression of connexin43. Carcinogenesis. 2004;25(10):1973-1982. (Pubitemid 39405918)
17. Dagli ML, Yamasaki H, Krutovskikh V, Omori Y. Delayed liver regeneration and increased susceptibility to chemical hepatocarcinogenesis in transgenic mice expressing a dominant-negative mutant of connexin32 only in the liver. Carcinogenesis. 2004;25(4):483-492. (Pubitemid 38499938)
18. King TJ, Lampe PD. The gap junction protein connexin32 is a mouse lung tumor suppressor. Cancer Res. 2004;64(20):7191-7196. (Pubitemid 39372049)
19. Temme A, Buchmann A, Gabriel HD, Nelles E, Schwarz M, Willecke K. High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr Biol. 1997;7(9):713-716. (Pubitemid 27408873)
20. Rackauskas M, Neverauskas V, Skeberdis VA. Diversity and properties of connexin gap junction channels. Medicina (Kaunas). 2010;46(1):1-12.